Exploring sexual health in breast cancer patients at Jeanne de Flandre Hospital
Study of the Sexual Health of Patients Treated for Non-metastatic Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital : a Prospective Monocentric Cohort With Repeated Anonymous Self-administered Questionnaires.
This study looks at how breast cancer treatment affects the sexual health and quality of life of women after their treatment at Jeanne de Flandre Hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 65 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Lille Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Lille) |
| Trial ID | NCT04852926 on ClinicalTrials.gov |
What this trial studies
This observational study examines the sexual health of female patients treated for non-metastatic breast cancer who are being followed up at the Observatory of Fertility at Jeanne de Flandre Hospital. Participants will complete repeated anonymous self-administered questionnaires to assess how various factors, including oncology treatments, self-esteem, body image, anxiety, and depression, influence their sexual health and quality of life. The study aims to gather insights into the impact of breast cancer treatment on sexual health and marital satisfaction over time.
Who should consider this trial
Good fit: Ideal candidates are females aged 18 and older in a relationship, diagnosed with invasive breast cancer, and undergoing chemotherapy.
Not a fit: Patients who are not in a relationship or those with metastatic breast cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve the sexual health and quality of life for breast cancer survivors.
How similar studies have performed: Other studies have explored sexual health in cancer survivors, indicating that this area of research is important but may still have untested aspects.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female from 18 years * In a relationship with a man or a woman * Developing invasive carcinoma of breast cancer * Planned medical therapy project by chemotherapy * Followed up in the Observatory of fertility * Patient who gave written consent to participate in the study * Insured Social Patient * Patient willing to follow all study procedures and duration Exclusion Criteria: -
Where this trial is running
Lille
- Hop Jeanne de Flandre Chu Lille — Lille, France (Recruiting)
Study contacts
- Principal investigator: Carine Martin, MD — University Hospital, Lille
- Study coordinator: Carine Martin, MD
- Email: carine.martin@chru-lille.fr
- Phone: 0320445962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.